Pharmacology & ToxicologyJACC Basic to Translational SciencePeer-reviewed
Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit with GLP-1/Glucagon Agonism
Jake E. Doiron, Mahmoud H. Elbatreek, Huijing Xia…·David J. Lefer
This study shows H2S deficiency in HFpEF patients and models, and that H2S supplementation or combination with GLP-1/glucagon agonists improves HFpEF outcomes.